Kiniksa Pharmaceuticals International, plc (KNSA) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $677.56M | +60.1% |
| 2024 | $423.24M | +56.6% |
| 2023 | $270.26M | +22.7% |
| 2022 | $220.18M | +471.2% |
| 2021 | $38.54M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $677.56M | +60.1% |
| 2024 | $423.24M | +56.6% |
| 2023 | $270.26M | +22.7% |
| 2022 | $220.18M | +471.2% |
| 2021 | $38.54M | — |